Immuneel Therapeutics Pvt. Ltd.

Immuneel Therapeutics Pvt. Ltd. company information, Employees & Contact Information

Updated June 2026

Quick answer

Immuneel Therapeutics Pvt. Ltd. is a Biotechnology Research company and founded in 2018. It has approximately 91 employees on record. Contact data was last refreshed in June 2026. Find Immuneel Therapeutics Pvt. Ltd.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

A pioneering clinical stage startup company leading the Cell & Gene therapy revolution and are committed to bringing breakthrough cancer treatment to patients in India, making it accessible & affordable.

Company Details

Employees
91
Founded
2018
Address
29/p2, 8th Floor, A-Block Mazumdar Shaw Medical Center Narayana Hrudayalaya Health City, Hosur Road 258/a,bommasandra Industrial Area Anekal Taluk,india
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bengaluru, Karnataka
Looking for a particular Immuneel Therapeutics Pvt. Ltd. employee's phone or email?

Immuneel Therapeutics Pvt. Ltd. Questions

News

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics - PR Newswire

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics PR Newswire

ScaleReady awards $150,000 grant to Immuneel Therapeutics - BioSpectrum India

ScaleReady awards $150,000 grant to Immuneel Therapeutics BioSpectrum India

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma - Express Pharma

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma Express Pharma

Cell & gene therapy statrtup Immuneel unveils CAR-T cancer therapy in India - Business Standard

Cell & gene therapy statrtup Immuneel unveils CAR-T cancer therapy in India Business Standard

Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy today - Mint

Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy today Mint

Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO - BusinessLine

Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO BusinessLine

Immuneel Therapeutics launches CAR T-cell therapy for blood cancer in India - financialexpress.com

Immuneel Therapeutics launches CAR T-cell therapy for blood cancer in India financialexpress.com

taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable. - Business Wire

taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable. Business Wire

Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations - Entrepreneur

Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations Entrepreneur

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations - Inc42

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations Inc42

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies - Labiotech.eu

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies Labiotech.eu

Hospital Clínic-IDIBAPS and Immuneel Therapeutics announce a strategic collaboration to improve - Hospital Clínic Barcelona

Hospital Clínic-IDIBAPS and Immuneel Therapeutics announce a strategic collaboration to improve Hospital Clínic Barcelona

Immuneel Therapeutics unveils India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma - BioSpectrum India

Immuneel Therapeutics unveils India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma BioSpectrum India

Immuneel Therapeutics raises $15 million in funding - The Economic Times

Immuneel Therapeutics raises $15 million in funding The Economic Times

Biotech startup Immuneel Therapeutics raises Rs 100 Cr in Series A round extension - YourStory.com

Biotech startup Immuneel Therapeutics raises Rs 100 Cr in Series A round extension YourStory.com

Cancer and a bespoke therapy: Immuneel Therapeutics COO Dr Arun Anand weighs in - Moneycontrol

Cancer and a bespoke therapy: Immuneel Therapeutics COO Dr Arun Anand weighs in Moneycontrol

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr - Entrackr

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr Entrackr

Kiran Mazumdar-Shaw co-founded biotech startup raises $15 mn in Series A funding - Mint

Kiran Mazumdar-Shaw co-founded biotech startup raises $15 mn in Series A funding Mint

Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in India - The Economic Times

Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in India The Economic Times

Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 crore in funding - Indian Startup News

Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 crore in funding Indian Startup News

[Funding alert] Biotech startup Immuneel Therapeutics raises $15M in Series A round - YourStory.com

[Funding alert] Biotech startup Immuneel Therapeutics raises $15M in Series A round YourStory.com

Cell therapy cancer centre takes shape in Bengaluru, trials are on - The Indian Express

Cell therapy cancer centre takes shape in Bengaluru, trials are on The Indian Express

Amit Mookim steps in as CEO of Immuneel Therapeutics - BioSpectrum India

Amit Mookim steps in as CEO of Immuneel Therapeutics BioSpectrum India

Immuneel Therapeutics welcomes Amit Mookim as CEO - Express Pharma

Immuneel Therapeutics welcomes Amit Mookim as CEO Express Pharma

Immuneel Therapeutics appoints Amit Mookim as CEO - Pharmabiz.com

Immuneel Therapeutics appoints Amit Mookim as CEO Pharmabiz.com

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics - Moneycontrol

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics Moneycontrol

Scaling CAR-T for India: How ScaleReady’s G-Rex grant is empowering Immuneel Therapeutic - BioSpectrum India

Scaling CAR-T for India: How ScaleReady’s G-Rex grant is empowering Immuneel Therapeutic BioSpectrum India

Immuneel to offer affordable cell and gene therapy for cancer patients in India - Express Pharma

Immuneel to offer affordable cell and gene therapy for cancer patients in India Express Pharma

Join Immuneel Therapeutics as a Downstream Process Development Scientist, Apply Now! - BioTecNika

Join Immuneel Therapeutics as a Downstream Process Development Scientist, Apply Now! BioTecNika

Immuneel Therapeutics Launches India’s First CAR T-cell Therapy for Non-Hodgkin’s Lymphoma - Digital Health News

Immuneel Therapeutics Launches India’s First CAR T-cell Therapy for Non-Hodgkin’s Lymphoma Digital Health News

Immuneel acquires exclusive license to CD19 CAR T Product for the Potential Treatment of B Cell Malignancies for India - BW Healthcare World

Immuneel acquires exclusive license to CD19 CAR T Product for the Potential Treatment of B Cell Malignancies for India BW Healthcare World

Kiran Mazumdar Shaw's Co-Founded Immuneel Therapeutics Secures $15 Mn Funding - BW Businessworld

Kiran Mazumdar Shaw's Co-Founded Immuneel Therapeutics Secures $15 Mn Funding BW Businessworld

Immuneel Therapeutics began patient dosing in a CAR-T trial named "IMAGINE" - Healthcare Radius

Immuneel Therapeutics began patient dosing in a CAR-T trial named "IMAGINE" Healthcare Radius

Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru - Express Pharma

Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru Express Pharma

Immuneel Therapeutics launches low cost treatment for blood cancer - drugscontrol.org

Immuneel Therapeutics launches low cost treatment for blood cancer drugscontrol.org

Biotech startup Immuneel Therapeutics raised $15 million in Series A round of funding led by Eight Roads - Startup Story

Biotech startup Immuneel Therapeutics raised $15 million in Series A round of funding led by Eight Roads Startup Story

Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022 - Express Pharma

Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022 Express Pharma

Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy - Express Pharma

Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy Express Pharma

Top Immuneel Therapeutics Pvt. Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant